Department of Medicine Archive — Page 64 of 120
-
February 11, 2021
Vanderbilt, Zambia researchers find delirium in hospitalized patients linked to mortality, disability in Sub-Saharan Africa
Delirium, a form of acute brain dysfunction, is widespread in critically ill patients in lower resourced hospitals, and the duration of delirium predicted both mortality and disability at six months after discharge, according to a study published in PLOS ONE. -
February 11, 2021
Clinical Trials Unit lands major grant renewal
Vanderbilt University Medical Center and Washington University School of Medicine in St. Louis have received renewal of a major federal grant to continue their collaboration to test and develop new treatments and vaccines against HIV/AIDS — and now COVID-19. -
February 10, 2021
Vanderbilt Health now offering endoscopy at One Hundred Oaks
The new Endoscopy Lab at One Hundred Oaks has expanded Vanderbilt Health’s options for endoscopic procedures including colonoscopies to screen for colorectal cancer. -
February 5, 2021
Convalescent plasma improved survival in COVID-19 patients with blood cancers
Treatment with convalescent plasma vastly improved the survival rate of patients hospitalized for COVID-19 who also had hematologic malignances that compromise the immune system, according to new data released by the COVID-19 and Cancer Consortium (CCC19). -
February 4, 2021
New clue to postural tachycardia
Insight into the pathophysiology of an enigmatic and debilitating disease suggests new treatment approaches. -
February 4, 2021
Device offers less invasive option to treat emphysema
Life with emphysema, a lung condition that causes shortness of breath, can be miserable. People with advanced emphysema, a form of chronic obstructive pulmonary disease (COPD), are so short of breath they may need supplemental oxygen just to walk from room to room. They often have trouble with everyday tasks like bathing or cooking a meal. -
February 4, 2021
Potential biomarker for IBD severity, cancer risk identified
A selenium transport protein produced in the colon may be a novel biomarker for assessing disease severity and cancer risk in patients with inflammatory bowel disease.